If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

DYN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 42.34%

Insider Buying (Last 12 Months): $10,000,016.70

Insider Selling (Last 12 Months): $3,168,469.41

Dyne Therapeutics Insider Trading History Chart

Dyne Therapeutics Share Price & Price History

^$11.58

▲ +0.43 (3.86%)

As of 03/30/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Dyne Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/14/2023	Richard William Scalzo	Insider	Sell	1,311	$13.33	$17,475.63	54,872
3/14/2023	Susanna High	COO	Sell	1,559	$13.33	$20,781.47	110,476
1/18/2023	Jonathan Mcneill	Insider	Sell	10,000	$14.03	$140,300.00	67,600
1/9/2023	Jonathan Mcneill	Insider	Sell	30,150	$11.57	$348,835.50	67,600
12/12/2022	Jason P Rhodes	Director	Buy	934,581	$10.70	$10,000,016.70	934,581
12/12/2022	Richard William Scalzo	Insider	Sell	312	$10.87	$3,391.44	56,183
12/12/2022	Susanna High	COO	Sell	751	$10.87	$8,163.37	112,035
10/10/2022	Joshua T Brumm	Insider	Sell	195,800	$12.46	$2,439,668.00	204,623
10/7/2022	Joshua T Brumm	Insider	Sell	14,200	$13.37	$189,854.00	204,623
3/11/2022	Richard William Scalzo	Insider	Sell	308	$8.73	$2,688.84
3/11/2022	Susanna High	COO	Sell	765	$8.73	$6,678.45
3/2/2022	Wildon Farwell	Insider	Sell	5,617	$8.56	$48,081.52
9/23/2021	Susanna High	COO	Sell	2,451	$17.22	$42,206.22
9/20/2021	Richard William Scalzo	Insider	Sell	367	$15.61	$5,728.87

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Dyne Therapeutics (NASDAQ:DYN)

85.50% of Dyne Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Dyne Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/16/2023	Alliancebernstein L.P.	314,588	$3.65M	0.0%	+17.2%	0.603%
2/15/2023	Public Employees Retirement System of Ohio	77,619	$0.90M	0.0%	-13.6%	0.149%
2/15/2023	Jane Street Group LLC	95,751	$1.11M	0.0%	N/A	0.184%
2/15/2023	Sphera Funds Management LTD.	7,149	$83K	0.0%	N/A	0.014%
2/15/2023	State of Wisconsin Investment Board	24,830	$0.29M	0.0%	-28.3%	0.048%
2/15/2023	Millennium Management LLC	254,110	$2.95M	0.0%	+210.1%	0.487%
2/15/2023	Morgan Stanley	64,430	$0.75M	0.0%	-50.3%	0.124%
2/15/2023	Norges Bank	157,752	$1.83M	0.0%	N/A	0.303%
2/15/2023	Algert Global LLC	153,645	$1.78M	0.1%	-0.9%	0.295%
2/15/2023	Atlas Venture Life Science Advisors LLC	9,869,483	$114.39M	13.8%	+10.5%	18.932%
2/15/2023	Braidwell LP	753,145	$8.73M	0.3%	N/A	1.445%
2/14/2023	Point72 Asset Management L.P.	1,387,668	$16.08M	0.1%	-7.3%	2.662%
2/14/2023	Susquehanna International Group LLP	17,024	$0.20M	0.0%	-36.1%	0.033%
2/14/2023	Putnam Investments LLC	39,818	$0.46M	0.0%	N/A	0.076%
2/14/2023	Marshall Wace LLP	22,052	$0.26M	0.0%	-66.0%	0.042%
2/14/2023	Two Sigma Investments LP	155,349	$1.80M	0.0%	+812.5%	0.298%
2/14/2023	EcoR1 Capital LLC	2,322,384	$26.92M	0.8%	N/A	4.455%
2/13/2023	Charles Schwab Investment Management Inc.	228,142	$2.64M	0.0%	+2.6%	0.438%
2/13/2023	Deutsche Bank AG	18,400	$0.21M	0.0%	+29.7%	0.035%
2/13/2023	Barclays PLC	24,243	$0.28M	0.0%	+41.9%	0.047%
2/13/2023	Renaissance Technologies LLC	107,700	$1.25M	0.0%	+2.7%	0.207%
2/13/2023	Martingale Asset Management L P	35,266	$0.41M	0.0%	N/A	0.068%
2/13/2023	Geode Capital Management LLC	546,555	$6.33M	0.0%	+2.4%	1.048%
2/13/2023	JPMorgan Chase & Co.	20,444	$0.24M	0.0%	-53.3%	0.039%
2/10/2023	Bank of America Corp DE	35,766	$0.42M	0.0%	-29.6%	0.069%
2/10/2023	Franklin Resources Inc.	1,778,301	$20.61M	0.0%	-0.3%	3.411%
2/10/2023	HRT Financial LP	16,882	$0.20M	0.0%	N/A	0.032%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	17,123	$0.20M	0.0%	+22.7%	0.033%
2/9/2023	Dimensional Fund Advisors LP	455,988	$5.28M	0.0%	+58.5%	0.875%
2/9/2023	Principal Financial Group Inc.	10,669	$0.12M	0.0%	N/A	0.020%
2/9/2023	Monashee Investment Management LLC	123,719	$1.43M	0.6%	-38.1%	0.237%
2/9/2023	Denali Advisors LLC	2,700	$31K	0.0%	-43.8%	0.005%
2/9/2023	Citigroup Inc.	10,169	$0.12M	0.0%	-92.0%	0.020%
2/8/2023	Raymond James & Associates	55,367	$0.64M	0.0%	-4.9%	0.106%
2/8/2023	UBS Group AG	9,576	$0.11M	0.0%	+815.5%	0.018%
2/8/2023	Swiss National Bank	62,500	$0.72M	0.0%	+2.8%	0.120%
2/8/2023	Russell Investments Group Ltd.	17,889	$0.21M	0.0%	-46.0%	0.034%
2/1/2023	International Biotechnology Trust PLC	641,068	$7.42M	2.3%	+83.1%	1.230%
2/1/2023	DekaBank Deutsche Girozentrale	15,000	$0.17M	0.0%	N/A	0.029%
12/8/2022	Bank of New York Mellon Corp	119,566	$1.52M	0.0%	+9.2%	0.229%
11/16/2022	Alpha Paradigm Partners LLC	34,630	$0.44M	0.2%	N/A	0.066%
11/15/2022	Alliancebernstein L.P.	268,525	$3.41M	0.0%	+8.0%	0.515%
11/15/2022	State Street Corp	578,880	$7.35M	0.0%	+3.4%	1.111%
11/15/2022	Public Employees Retirement System of Ohio	89,793	$1.14M	0.0%	N/A	0.172%
11/15/2022	Jacobs Levy Equity Management Inc.	221,048	$2.81M	0.0%	N/A	0.424%
11/15/2022	Algert Global LLC	155,095	$1.97M	0.1%	+735.9%	0.298%
11/15/2022	Two Sigma Advisers LP	40,000	$0.51M	0.0%	+64.6%	0.077%
11/15/2022	Two Sigma Investments LP	17,024	$0.22M	0.0%	N/A	0.033%
11/15/2022	Trexquant Investment LP	36,567	$0.46M	0.0%	N/A	0.070%
11/15/2022	Vanguard Group Inc.	1,338,365	$17M	0.0%	+1.3%	2.568%
11/15/2022	Price T Rowe Associates Inc. MD	38,708	$0.49M	0.0%	+5.9%	0.074%
11/15/2022	Logos Global Management LP	2,287,321	$29.05M	3.6%	-21.1%	4.388%
11/15/2022	Marshall Wace LLP	64,910	$0.82M	0.0%	-81.4%	0.125%
11/15/2022	Ensign Peak Advisors Inc	44,270	$0.56M	0.0%	+10.7%	0.085%
11/15/2022	Bank of New York Mellon Corp	119,566	$1.52M	0.0%	+9.2%	0.229%
11/15/2022	BlackRock Inc.	2,525,067	$32.07M	0.0%	+2.0%	4.844%
11/14/2022	Tudor Investment Corp Et Al	26,200	$0.33M	0.0%	-62.6%	0.050%
11/14/2022	Point72 Asset Management L.P.	1,497,631	$19.02M	0.1%	+9.6%	2.873%
11/14/2022	Cubist Systematic Strategies LLC	27,030	$0.34M	0.0%	+17,226.9%	0.052%
11/14/2022	PDT Partners LLC	19,705	$0.25M	0.0%	-12.9%	0.038%
11/14/2022	Renaissance Technologies LLC	104,900	$1.33M	0.0%	+15.0%	0.201%
11/14/2022	Nuveen Asset Management LLC	161,666	$2.05M	0.0%	-19.4%	0.310%
11/14/2022	UBS Oconnor LLC	176,490	$2.24M	0.0%	-22.4%	0.339%
11/10/2022	Dimensional Fund Advisors LP	287,601	$3.65M	0.0%	+247.4%	0.552%
11/10/2022	Tower Research Capital LLC TRC	9,582	$0.12M	0.0%	+425.0%	0.018%
11/8/2022	International Biotechnology Trust PLC	350,068	$4.44M	1.4%	+8,957.4%	0.672%
11/7/2022	Jump Financial LLC	30,188	$0.38M	0.0%	N/A	0.058%
11/4/2022	Russell Investments Group Ltd.	33,111	$0.42M	0.0%	N/A	0.064%
11/3/2022	Financial Management Network Inc.	40,000	$0.40M	0.2%	N/A	0.077%
11/3/2022	Barclays PLC	17,079	$0.22M	0.0%	-78.5%	0.033%
11/1/2022	Monashee Investment Management LLC	200,000	$2.54M	0.9%	-37.4%	0.386%
10/27/2022	Assenagon Asset Management S.A.	263,026	$3.34M	0.0%	-1.3%	0.508%
10/27/2022	Strs Ohio	13,200	$0.17M	0.0%	N/A	0.026%
10/25/2022	Denali Advisors LLC	4,800	$61K	0.0%	N/A	0.009%
10/25/2022	Raymond James & Associates	58,207	$0.74M	0.0%	N/A	0.112%
10/5/2022	Vida Ventures Advisors LLC	2,220,034	$28.19M	25.3%	-25.0%	4.289%
8/22/2022	Legal & General Group Plc	12,757	$88K	0.0%	+59.9%	0.025%
8/18/2022	Goldman Sachs Group Inc.	66,043	$0.45M	0.0%	-15.9%	0.128%
8/16/2022	Woodline Partners LP	666,997	$4.58M	0.1%	-18.0%	1.289%
8/16/2022	International Biotechnology Trust PLC	3,865	$0.56M	5.9%	-99.2%	0.007%
8/15/2022	State Street Corp	559,688	$3.85M	0.0%	+11.7%	1.081%
8/15/2022	PDT Partners LLC	22,623	$0.16M	0.0%	-16.9%	0.044%
8/15/2022	Point72 Asset Management L.P.	1,366,400	$9.39M	0.0%	-27.6%	2.640%
8/15/2022	Citadel Advisors LLC	2,925,714	$20.10M	0.0%	-1.2%	5.652%
8/13/2022	Renaissance Technologies LLC	91,200	$0.63M	0.0%	+113.6%	0.176%
8/12/2022	Northern Trust Corp	266,038	$1.83M	0.0%	+3.7%	0.514%
8/12/2022	Credit Suisse AG	18,015	$0.12M	0.0%	+10.6%	0.035%
8/12/2022	Franklin Resources Inc.	1,746,481	$12M	0.0%	+48.3%	3.374%
8/12/2022	Rhumbline Advisers	44,382	$0.31M	0.0%	+18.5%	0.086%
8/11/2022	Bank of Montreal Can	41,304	$0.29M	0.0%	N/A	0.080%
8/11/2022	JPMorgan Chase & Co.	35,320	$0.24M	0.0%	+26.8%	0.068%
8/9/2022	Swiss National Bank	60,800	$0.42M	0.0%	+10.7%	0.117%
8/3/2022	Candriam S.C.A.	413,624	$2.84M	0.0%	+27.9%	0.801%
7/29/2022	SG Americas Securities LLC	10,751	$74K	0.0%	N/A	0.021%
7/27/2022	Assenagon Asset Management S.A.	266,612	$1.83M	0.0%	-9.7%	0.516%
6/30/2022	Amalgamated Bank	3,631	$35K	0.0%	N/A	0.007%
6/7/2022	Bank of America Corp DE	32,772	$0.32M	0.0%	-48.8%	0.063%
5/17/2022	Royal Bank of Canada	3,009	$29K	0.0%	-59.5%	0.006%
5/16/2022	California State Teachers Retirement System	32,479	$0.31M	0.0%	-8.9%	0.063%
5/16/2022	Goldman Sachs Group Inc.	78,557	$0.76M	0.0%	-7.2%	0.152%

Data available starting January 2016

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..

Today's Range

Now: $11.58

$11.00

$11.63

50 Day Range

MA: $13.18

$10.88

$15.00

52 Week Range

Now: $11.58

$4.30

$15.63

Volume

516,043 shs

Average Volume

313,934 shs

Market Capitalization

$652.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.28

Who are the company insiders with the largest holdings of Dyne Therapeutics?: Dyne Therapeutics' top insider shareholders include:
Jason P Rhodes (Director)
Joshua T Brumm (Insider)
Susanna Gatti High (COO)
Jonathan Mcneill (Insider)
Richard William Scalzo (Insider)
Wildon Farwell (Insider)
Learn More about top insider investors at Dyne Therapeutics.
Who are the major institutional investors of Dyne Therapeutics?: Dyne Therapeutics' top institutional shareholders include:
Atlas Venture Life Science Advisors LLC — 18.93%
EcoR1 Capital LLC — 4.45%
Franklin Resources Inc. — 3.41%
Point72 Asset Management L.P. — 2.66%
Braidwell LP — 1.44%
International Biotechnology Trust PLC — 1.23%
Learn More about top institutional investors of Dyne Therapeutics stock.
Which major investors are selling Dyne Therapeutics stock?: In the previous quarter, DYN stock was sold by these institutional investors:
Citigroup Inc.
Point72 Asset Management L.P.
Monashee Investment Management LLC
Morgan Stanley
Marshall Wace LLP
JPMorgan Chase & Co.
Russell Investments Group Ltd.
Bank of America Corp DE
Within the last year, company insiders that have sold Dyne Therapeutics company stock include:
Jason P Rhodes (Director)
Joshua T Brumm (Insider)
Susanna Gatti High (COO)
Jonathan Mcneill (Insider)
Learn More investors selling Dyne Therapeutics stock.
Which major investors are buying Dyne Therapeutics stock?: In the last quarter, DYN stock was purchased by institutional investors including:
EcoR1 Capital LLC
Atlas Venture Life Science Advisors LLC
Braidwell LP
International Biotechnology Trust PLC
Millennium Management LLC
Dimensional Fund Advisors LP
Norges Bank
Two Sigma Investments LP

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

DYN Insider Trading

Dyne Therapeutics Insider Trading History Chart

Dyne Therapeutics Share Price & Price History

Dyne Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Dyne Therapeutics (NASDAQ:DYN)

Institutional Buying and Selling by Quarter

Dyne Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Dyne Therapeutics?

Who are the major institutional investors of Dyne Therapeutics?

Which major investors are selling Dyne Therapeutics stock?

Which major investors are buying Dyne Therapeutics stock?